Model N Announces New Chief Marketing Officer

SAN MATEO, Calif.–(BUSINESS WIRE)–Model N, Inc. (NYSE: MODN), the leading provider of cloud revenue management solutions for the pharmaceutical, medical device, high-tech manufacturing and semiconductor industries, today announced that Dave Michaud has joined as Chief Marketing Officer. Mr. Michaud brings over two decades of marketing leadership experience at high-growth software companies such as Oracle, VMware, Taleo, and Eloqua.

“We are thrilled to have Dave join Model N as our Chief Marketing Officer,” said Jason Blessing, Chief Executive Officer at Model N. “His extensive experience developing and executing go-to-market strategies will help us grow and deepen our leadership in our core markets of life sciences and high tech. Dave is a proven marketing executive with a strong cultural fit who will help take our marketing efforts to the next level.”

“I am very happy to be joining the Model N team,” said Michaud. “The company serves the complex needs of some of the world’s biggest companies and I am excited to help them on their journey. I look forward to telling our story, deepening our customer relationships, and driving global demand.”

Dave brings over two decades of senior marketing leadership in high-growth software companies. He is a marketing executive with a proven track record creating categories, entering new markets, driving market leadership, and building world-class teams. Most recently he was senior vice president of marketing at Plex. Dave previously held marketing leadership positions at Taleo, Eloqua, VMware, PeopleSoft, and Oracle.

About Model N

Model N is a leading provider of cloud revenue management solutions for life sciences and high tech companies. Driving mission-critical business processes such as pricing, quoting, contracting, regulatory compliance, rebates and incentives, our software helps companies know and grow their true top line and maximize every revenue moment at speed and scale. With deep industry expertise, Model N supports the complex business needs of the world’s leading brands in pharmaceutical, medical technology, semiconductor, and high-tech manufacturing across more than 100 countries, including Johnson & Johnson, AstraZeneca, Novartis, Microchip Technology and ON Semiconductor. For more information, visit www.modeln.com.

Contacts

Sherri Walkenhorst

801.373.7888

swalkenhorst@modeln.com

Staff

Recent Posts

GE HealthCare Announces Cash Dividend for First Quarter of 2024

CHICAGO--(BUSINESS WIRE)--The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC) today declared a…

59 mins ago

GE HealthCare to Feature Latest Technologies in Interventional Radiology Focused on Precision Care at SIR 2024

Multi-modality showcase brings hands-on experience to care delivery for a wide range of vascular diseases…

1 hour ago

Smartsheet Names Katie Rooney to Board of Directors

Experienced global CFO adds depth in financial strategy and operating excellence to Smartsheet boardBELLEVUE, Wash.--(BUSINESS…

1 hour ago

The Centers for Medicare & Medicaid Services Revise National Coverage Determination for Stem Cell Transplantation

The Centers for Medicare & Medicaid Services revise the National Coverage Determination of allogeneic hematopoietic…

1 hour ago

Cocrystal Pharma Receives Pre-IND Responses from the FDA on Oral CC-42344 for Treating Influenza A

Feedback provides greater clarity on regulatory requirements for planned Phase 2b trial BOTHELL, Wash. (March…

2 hours ago